HDAC4-Regulated STAT1 Activation Mediates Platinum Resistance in Ovarian Cancer

Euan A. Stronach(Age UK), Hani Gabra(Royal Children's Hospital)

Cancer Research

May 13, 2011

10.1158/0008-5472.can-10-4111

Cited by 179

Related Papers

Rethinking ovarian cancer: recommendations for improving outcomes

|Nature reviews. Cancer|2011|1.5k

Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer

|Nature reviews. Cancer|2015|1.4k

Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens

|Nature|2019|1.4k

Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial

|The Lancet|2019|223

LARP1 post-transcriptionally regulates mTOR and contributes to cancer progression

|Oncogene|2014|152